Estramustine phosphate (Emcyt) as treatment for metastatic renal carcinoma |
| |
| Authors: | David A Swanson Douglas E Johnson |
| |
| Institution: | From the Department of Urology, The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas, USA |
| |
| Abstract: | Sixteen patients completed an adequate trial of estramustine phosphate for the management of metastatic renal cell carcinoma. Although no patient showed a complete or partial response, 9 (56 per cent) had stabilization of disease for a median of 44 weeks. Toxicity was not severe, but intolerance to the drug may limit its widespread use. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
